Skip to main content

Table 1 Clinical and demographic features of COVID-19 patients in Shiraz, South of Iran

From: Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran

VariableTotal (%) n = 113Severe
n = 11
Non-severe
n = 102
P.valueDeathn = 9Liven = 104P.value
Age (years)
 20–3413 (11.5)1 (7.7)12 (92.3)0.7501 (7.7)12 (92.3)0.899
 35–4936 (31.9)2 (5.6)34 (94.4)2 (5.6)34 (94.4)
 50–6436 (31.9)5 (13.9)31 (86.1)3 (8.3)33 (91.7)
 65–7414 (12.4)2 (14.3)12 (85.7)1 (7.1)13 (92.9)
  ≥ 7514 (12.4)1 (7.1)13 (92.9)2 (14.3)12 (85.7)
Sex
 Male71 (62.8)7 (9.9)64 (90.1)0.7505 (7)66 (93)0.725
 Female42 (37.2)4 (9.5)38 (90.5)4 (9.5)38 (90.5)
Occupation
 Healthcare worker3 (2.8)0 (0)3 (100)1.0000 (0)3 (100)1.000
 Non-healthcare worker103 (97.2)9 (8.7)94 (91.3)9 (8.7)94 (91.3)
History of Contact with infected cases19 (16.8)0 (0)19 (100)0.2060 (0)19 (100)0.353
History of travelling30 (26.5)3 (10)27 (90)1.0002 (6.7)28 (93.3)1.000
Comorbid Disease
 Hypertension22 (19.5)5 (22.7)17 (77.3)0.0372 (9.1)20 (90.9)1.000
 Diabetes16 (14.2)3 (18.8)13 (81.3)0.1882 (12.5)14 (87.5)0.613
 Cardiovascular disease16 (14.2)4 (25)12 (75)0.0492 (12.5)14 (87.5)0.613
 Malignancy1 (0.9)0 (0)1 (100)1.0000 (0)1 (100)1.000
 Asthma7 (6.2)1 (14.3)6 (85.7)0.5221 (14.3)6 (85.7)0.450
 Chronic obstructive Pulmonary disease9 (8.0)1 (11.1)8 (88.9)1.0001 (11.1)8 (88.9)0.540
 Chronic kidney disease6 (5.3)0 (0)6 (100)1.0000 (0)6 (100)1.000
 Other Immunosuppressive diseases2 (1.8)0 (0)2 (100)1.0000 (0)2 (100)1.000
Symptoms at onset of illness
 Fever67 (59.3)5 (7.5)62 (92.5)0.3503 (4.5)64 (95.5)0.156
 Cough73 (64.6)5 (6.8)68 (93.2)0.1935 (6.8)68 (93.2)0.718
 Fatigue75 (66.4)10 (13.3)65 (86.7)0.0968 (10.7)67 (89.3)0.268
 Sputum production24 (21.4)2 (8.3)22 (91.7)1.0004 (16.7)20 (83.3)0.097
 Dyspnea58 (51.3)8 (13.8)50 (86.2)0.2054 (6.9)54 (93.1)0.738
 Chest pain43 (38.1)6 (14)37 (86)0.3283 (7)40 (93)1.000
 Chills67 (59.3)4 (6)63 (94)0.1143 (4.5)64 (95.5)0.153
 Hemoptysis7 (6.2)0 (0)7 (100)1.0000 (0)7 (100)1.000
 Rhinorrhea26 (23.0)1 (3.8)25 (96.2)0.4522 (7.7)24 (92.3)1.000
 Sore throat36 (31.9)3 (8.3)33 (91.7)1.0002 (5.6)34 (94.4)0.716
 Abdominal pain24 (21.2)2 (8.3)22 (91.7)1.0002 (8.3)22 (91.7)1.000
 Diarrhea25 (22.1)1 (4)24 (96)0.4512 (8)23 (92)1.000
 Nausea48 (42.5)5 (10.4)43 (89.6)1.0005 (10.4)43 (89.6)0.491
 Vomiting29 (25.7)2 (6.9)27 (93.1)0.7254 (13.8)25 (86.2)0.234
 Anorexia75 (66.4)9 (12)66 (88)0.3298 (10.7)67 (89.3)0.268
 Myalgia /Arthralgia69 (61.1)7 (10.1)62 (89.9)1.0005 (7.2)64 (92.8)0.734
 Headache60 (53.1)5 (8.3)55 (91.7)0.7536 (10)54 (90)0.498
 Dizziness/ Vertigo45 (39.8)7 (15.6)38 (84.4)0.1116 (13.3)39 (86.7)0.152
 Conjunctival congestion17 (15.0)2 (11.8)15 (88.2)0.6702 (11.8)15 (88.2)0.622
Physical exam on admission
Temperature
   < 37.377 (68.1)8 (10.4)69 (89.6)0.0056 (7.8)71 (92.2)0.002
  37.3–3824 (21.2)0 (0)24 (100)0 (0)24 (100)
  38.1–3911 (9.7)2 (18.2)9 (81.8)2 (18.2)9 (81.8)
   > 391 (0.9)1 (0.9)0 (0)1 (100)0 (0)
Heart Rate
   > 100 (beats/min)12 (10.6)1 (7.7)12 (92.3)1.0001 (7.7)12 (92.3)1.000
Respiratory Rate
   > 24(breaths/min)2 (1.8)1 (50)1 (50)0.1861 (50)1 (50)0.154
Blood Pressure
  Normal36 (32.4)4 (11.1)32 (88.9)0.7384 (11.1)32 (88.9)0.617
  Elevated7 (6.3)7 (10)63 (90)5 (7.1)65 (92.9)
Saturation of O2
   < 9039 (34.5)7 (17.9)32 (82.1)0.046a4 (5.4)70 (94.6)0.271
   ≥ 9074 (65.5)4 (5.4)70 (94.6)5 (12.8)34 (87.2)
Lung Auscultation
  Respiratory Rales27 (23.9)7 (25.9)20 (74.1)0.004a3 (11.1)24.(88.9)0.444
  Respiratory Wheeze8 (7.1)0 (0)8 (100)1.0000 (0)8 (100)1.000
  Respiratory Stridor10 (8.8)1 (10)9 (90)1.0001 (10)9 (90)0.580
Other Infection Signs
  Throat Congestion17 (15.0)4 (23.5)13 (76.5)0.0601 (5.9)16 (94.1)1.000
  Swelling of tonsils8 (7.1)1 (12.5)7 (87.5)0.5710 (0)8 (100)1.000
  Lymphadenopathy3 (2.7)1 (33.3)2 (66.7)0.2670 (0)3 (100)1.000
  Rash6 (5.3)0 (0)6 (100)1.0001 (16.7)5 (83.3)0.377
Treatment
  Anti-Viral therapy113 (100.0)11 (9.7)102 (90.3)NA9 (8)104 (92)NA
  Antibiotic therapy112 (99.1)11 (9.8)101 (90.2)1.0009 (8)103 (92)1.000
  Use of Corticosteroid5 (4.4)2 (40)3 (60)0.0741 (20)4 (80)0.345
Oxygen support
  Nasal cannula31 (27.4)1 (3.2)30 (96.8)0.2851 (3.2)30 (96.8)0.440
  Noninvasive ventilation or high flow mask11 (9.8)6 (54.5)5 (45.5)0.000a1 (9.1)10 (90.9)1.000
  Invasive mechanical ventilation2 (1.8)2 (100)0.0000.009a2 (100)0 (0)0.006a
Prognosis
  Hospitalization29 (25.7)2 (6.9)27 (93.1)0.000a0 (0)29 (100)0.000a
  Discharge with continued OPD treatment7 (6.2)1 (14.3)6 (85.7)0 (0)7 (100)
  Total Recovery68 (60.2)3 (4.4)65 (95.6)0 (0)68 (100)
  Death in course of Hospitalization9 (8)5 (55.6)4 (44.4)9 (100)0 (0)
  1. a indicator of significant correlation; NA: not applicable